During a session at the this week’s World Stem Cell Summit in San Diego, an international research team described an “astonishing” experiment in which a mouse model of multiple sclerosis was able to virtually totally recover and move normally after being transplanted with human neural precursor cells (hNPC). The scientists were able to show almost full recovery in the mice up to six months later.
Recent Posts
- Podcast – SENESCENT CELLS – An Important Target for Diseases of Aging
- Q&A: The Future of Space Medicine Research
- Trump administration halts use of human fetal tissue in NIH-funded research
- Bone cancer therapy unexpectedly makes tumours less painful
- Scientists solve a major roadblock holding back cancer cell therapy
- The Potential of Stem Cells to Improve Stroke Treatment
